A pathogenic IFNα, BLyS and IL-17 axis in systemic lupus erythematosus patients

Scientific Reports

Volumn 6, Issue , 2016, Pages

  López, Patricia ^a   Rodríguez Carrio, Javier ^a   Caminal Montero, Luis ^b   Mozo, Lourdes ^b   Suárez, Ana ^a  

^a UNIVERSITY OF OVIEDO   (Spain)

^b HOSPITAL UNIVERSITARIO CENTRAL DE ASTURIAS   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA INTERFERON; B CELL ACTIVATING FACTOR; INTERLEUKIN 17; TNFSF13B PROTEIN, HUMAN;

ADULT; B LYMPHOCYTE; BLOOD; FEMALE; HUMAN; MALE; METABOLISM; MIDDLE AGED; NEUTROPHIL; SYSTEMIC LUPUS ERYTHEMATOSUS; TH17 CELL; UPREGULATION;

ADULT; B-CELL ACTIVATING FACTOR; B-LYMPHOCYTES; FEMALE; HUMANS; INTERFERON-ALPHA; INTERLEUKIN-17; LUPUS ERYTHEMATOSUS, SYSTEMIC; MALE; MIDDLE AGED; NEUTROPHILS; TH17 CELLS; UP-REGULATION;

EID: 84957547986     PISSN: None     EISSN: 20452322     Source Type: Journal    
DOI: 10.1038/srep20651     Document Type: Article

References (63)

1. Hua, J., Kirou, K., Lee, C., & Crow, M. K. Functional assay of type I interferon in systemic lupus erythematosus plasma and association with anti-RNA binding protein autoantibodies. Arthritis Rheum. 54, 1906-1916 (2006).
2. Crow, M. K., & Type I Interferon in the Pathogenesis of Lupus. J. Immunol. 192, 5459-5468 (2014).
3. Kirou, K. A., et al. Coordinate overexpression of interferon-Alpha-induced genes in systemic lupus erythematosus. Arthritis Rheum. 50, 3958-3967 (2004).
4. Bengtsson, A. A., et al. Activation of type I interferon system in systemic lupus erythematosus correlates with disease activity but not with antiretroviral antibodies. Lupus 9, 664-671 (2000).
5. Hooks, J. J., et al. Immune Interferon in the Circulation of Patients with Autoimmune Disease. N. Engl. J. Med. 301, 5-8 (1979).
6. Ytterberg, S. R., & Schnitzer, T. J. Serum interferon levels in patients with systemic lupus erythematosus. Arthritis Rheum. 25, 401-406 (1982).
7. Blanco, P., Palucka, A. K., Gill, M., Pascual, V., & Banchereau, J. Induction of dendritic cell differentiation by IFN-Alpha in systemic lupus erythematosus. Science 294, 1540-1543 (2001).
8. Theofilopoulos, A. N., Baccala, R., Beutler, B., & Kono, D. H. Type I interferons (alpha/beta) in immunity and autoimmunity. Annu. Rev. Immunol. 23, 307-336 (2005).
9. Nacionales, D. C., et al. Deficiency of the type I interferon receptor protects mice from experimental lupus. Arthritis Rheum. 56, 3770-3783 (2007).
10. Agrawal, H., et al. Deficiency of type I IFN receptor in lupus-prone New Zealand mixed 2328 mice decreases dendritic cell numbers and activation and protects from disease. J. Immunol. Baltim. Md 1950 183, 6021-6029 (2009).
11. Santiago-Raber, M.-L., et al. Type-I Interferon Receptor Deficiency Reduces Lupus-like Disease in NZB Mice. J. Exp. Med. 197, 777-788 (2003).
12. Schneider, P., et al. BAFF, a novel ligand of the tumor necrosis factor family, stimulates B cell growth. J. Exp. Med. 189, 1747-1756 (1999).
13. Moore, P. A., et al. BLyS: member of the tumor necrosis factor family and B lymphocyte stimulator. Science 285, 260-263 (1999).
14. Nardelli, B., et al. Synthesis and release of B-lymphocyte stimulator from myeloid cells. Blood 97, 198-204 (2001).
15. Chu, V. T., Enghard, P., Riemekasten, G., & Berek, C. In vitro and in vivo activation induces BAFF and APRIL expression in B cells. J. Immunol. Baltim. Md 1950 179, 5947-5957 (2007).
16. Collins, C. E., et al. B lymphocyte stimulator (BLyS) isoforms in systemic lupus erythematosus: disease activity correlates better with blood leukocyte BLyS mRNA levels than with plasma BLyS protein levels. Arthritis Res. Ther. 8, R6 (2006).
17. Petri, M., et al. Association of plasma B lymphocyte stimulator levels and disease activity in systemic lupus erythematosus. Arthritis Rheum. 58, 2453-2459 (2008).
18. McCarthy, E. M., et al. Elevated B lymphocyte stimulator levels are associated with increased damage in an Irish systemic lupus erythematosus cohort. Rheumatol. Oxf. Engl. 52, 1279-1284 (2013).
19. López, P., et al. Interferon-α-induced B-lymphocyte stimulator expression and mobilization in healthy and systemic lupus erthymatosus monocytes. Rheumatol. Oxf. Engl. (2014). doi: 10.1093/rheumatology/keu249
20. Litinskiy, M. B., et al. DCs induce CD40-independent immunoglobulin class switching through BLyS and APRIL. Nat. Immunol. 3, 822-829 (2002).
21. Mathian, A., Weinberg, A., Gallegos, M., Banchereau, J., & Koutouzov, S. IFN-α Induces Early Lethal Lupus in Preautoimmune (New Zealand Black New Zealand White)F1 but Not in BALB/c Mice. J. Immunol. 174, 2499-2506 (2005).
22. Yao, Y., et al. Neutralization of interferon-Alpha/beta-inducible genes and downstream effect in a phase I trial of an anti-interferonalpha monoclonal antibody in systemic lupus erythematosus. Arthritis Rheum. 60, 1785-1796 (2009).
23. Furie, R., et al. A phase III, randomized, placebo-controlled study of belimumab, a monoclonal antibody that inhibits B lymphocyte stimulator, in patients with systemic lupus erythematosus. Arthritis Rheum. 63, 3918-3930 (2011).
24. Manzi, S., et al. Effects of belimumab, a B lymphocyte stimulator-specific inhibitor, on disease activity across multiple organ domains in patients with systemic lupus erythematosus: combined results from two phase III trials. Ann. Rheum. Dis. 71, 1833-1838 (2012).
25. Li, D., et al. Interleukin-17 in systemic lupus erythematosus: A comprehensive review. Autoimmunity 1-9, doi: 10.3109/08916934.2015.1037441 (2015).
26. Bettelli, E., Oukka, M., & Kuchroo, V. K. T(H)-17 cells in the circle of immunity and autoimmunity. Nat. Immunol. 8, 345-350 (2007).
27. Shin, M. S., Lee, N., & Kang, I. Effector T-cell subsets in systemic lupus erythematosus: update focusing on Th17 cells. Curr. Opin. Rheumatol. 23, 444-448 (2011).
28. Shah, K., et al. Dysregulated balance of Th17 and Th1 cells in systemic lupus erythematosus. Arthritis Res. Ther. 12, 1-10 (2010).
29. Doreau, A., et al. Interleukin 17 acts in synergy with B cell-Activating factor to influence B cell biology and the pathophysiology of systemic lupus erythematosus. Nat. Immunol. 10, 778-785 (2009).
30. Mitsdoerffer, M., et al. Proinflammatory T helper type 17 cells are effective B-cell helpers. Proc. Natl. Acad. Sci. 107, 14292-14297 (2010).
31. Park, S. J., & Shin, J. I. Interleukin-17 and B cell-Activating factor in Kawasaki disease and juvenile systemic lupus erythematosus. Lupus 21, 1260 (2012).
32. Magnusson, M., Magnusson, S., Vallin, H., Rönnblom, L., & Alm, G. V. Importance of CpG dinucleotides in activation of natural IFN-Alpha-producing cells by a lupus-related oligodeoxynucleotide. Scand. J. Immunol. 54, 543-550 (2001).
33. Farkas, L., Beiske, K., Lund-Johansen, F., Brandtzaeg, P., & Jahnsen, F. L. Plasmacytoid dendritic cells (natural interferon-Alpha/ beta-producing cells) accumulate in cutaneous lupus erythematosus lesions. Am. J. Pathol. 159, 237-243 (2001).
34. Axtell, R. C., Raman, C., & Steinman, L. Type I interferons: beneficial in Th1 and detrimental in Th17 autoimmunity. Clin. Rev. Allergy Immunol. 44, 114-120 (2013).
35. Korn, T., Oukka, M., Kuchroo, V., & Bettelli, E. Th17 cells: Effector T cells with inflammatory properties. Semin. Immunol. 19, 362-371 (2007).
36. Vincent, F. B., Saulep-Easton, D., Figgett, W. A., Fairfax, K. A., & Mackay, F. The BAFF/APRIL system: Emerging functions beyond B cell biology and autoimmunity. Cytokine Growth Factor Rev. 24, 203-215 (2013).
37. Jørgensen, T. N., Roper, E., Thurman, J. M., Marrack, P., & Kotzin, B. L. Type I interferon signaling is involved in the spontaneous development of lupus-like disease in B6.Nba2 and (B6.Nba2 NZW)F1 mice. Genes Immun. 8, 653-662 (2007).
38. Braun, D., Geraldes, P., & Demengeot, J. Type I Interferon controls the onset and severity of autoimmune manifestations in lpr mice. J. Autoimmun. 20, 15-25 (2003).
39. Witowski, J., et al. IL-17 stimulates intraperitoneal neutrophil infiltration through the release of GROα chemokine from mesothelial cells. J. Immunol. 165, 5814-5821 (2000).
40. Ruddy, M. J., Shen, F., Smith, J. B., Sharma, A., & Gaffen, S. L. Interleukin-17 regulates expression of the CXC chemokine LIX/CXCL5 in osteoblasts: Implications for inflammation and neutrophil recruitment. J. Leukoc. Biol. 76, 135-144 (2004).
41. Agarwal, S., Misra, R., & Aggarwal, A. Interleukin 17 levels are increased in juvenile idiopathic arthritis synovial fluid and induce synovial fibroblasts to produce proinflammatory cytokines and matrix metalloproteinases. J. Rheumatol. 35, 515-519 (2008).
42. Wong, C. K., et al. Hyperproduction of IL-23 and IL-17 in patients with systemic lupus erythematosus: Implications for Th17-mediated inflammation in auto-immunity. Clin. Immunol. 127, 385-393 (2008).
43. Crispín, J. C., et al. Expanded double negative T cells in patients with systemic lupus erythematosus produce IL-17 and infiltrate the kidneys. J. Immunol. 181, 8761-8766 (2008).
44. Milanova, V., Ivanovska, N., & Dimitrova, P. TLR2 Elicits IL-17-Mediated RANKL Expression, IL-17, and OPG Production in Neutrophils from Arthritic Mice. Mediators Inflamm. 2014, e643406 (2014).
45. Cua, D. J., & Tato, C. M. Innate IL-17-producing cells: the sentinels of the immune system. Nat. Rev. Immunol. 10, 479-489 (2010).
46. Lai Kwan Lam, Q., King Hung Ko, O., Zheng, B.-J., & Lu, L. Local BAFF gene silencing suppresses Th17-cell generation and ameliorates autoimmune arthritis. Proc. Natl. Acad. Sci. USA 105, 14993-14998 (2008).
47. Meyers, J. A., et al. Blockade of TLR9 agonist-induced type I interferons promotes inflammatory cytokine IFN-gamma and IL-17 secretion by activated human PBMC. Cytokine 35, 235-246 (2006).
48. Cui, F., Meng, J., Luo, P., & Chen, P. IFN-Alpha blocks IL-17 production by peripheral blood mononuclear cells in patients with chronic active hepatitis B Infection. BMC Infect. Dis. 14, 55 (2014).
49. Hirohata, S., Shibuya, H., & Tejima, S. Suppressive influences of IFN-Alpha on IL-17 expression in human CD4+ T cells. Clin. Immunol. Orlando Fla 134, 340-344 (2010).
50. Liu, X., Yang, P., Wang, C., Li, F., & Kijlstra, A. IFN-Alpha blocks IL-17 production by peripheral blood mononuclear cells in Behcet?s disease. Rheumatol. Oxf. Engl. 50, 293-298 (2011).
51. Roers, A., Hochkeppel, H. K., Horisberger, M. A., Hovanessian, A., & Haller, O. MxA gene expression after live virus vaccination: a sensitive marker for endogenous type I interferon. J. Infect. Dis. 169, 807-813 (1994).
52. Horisberger, M. A. Interferon-induced human protein MxA is a GTPase which binds transiently to cellular proteins. J. Virol. 66, 4705-4709 (1992).
53. Oh, S. H., et al. Expression of interleukin-17 is correlated with interferon-α expression in cutaneous lesions of lupus erythematosus. Clin. Exp. Dermatol. 36, 512-520 (2011).
54. Ambrosi, A., Espinosa, A., & Wahren-Herlenius, M. IL-17: a new actor in IFN-Driven systemic autoimmune diseases. Eur. J. Immunol. 42, 2274-2284 (2012).
55. Harris, T. J., et al. Cutting edge: An in vivo requirement for STAT3 signaling in TH17 development and TH17-Dependent autoimmunity. J. Immunol. Baltim. Md 1950 179, 4313-4317 (2007).
56. van Boxel-Dezaire, A. H. H., Rani, M. R. S., & Stark, G. R. Complex modulation of cell type-specific signaling in response to type I interferons. Immunity 25, 361-372 (2006).
57. Brkic, Z., et al. T-helper 17 cell cytokines and interferon type I: partners in crime in systemic lupus erythematosus? Arthritis Res. Ther. 16, R62 (2014).
58. Farkas, A., Tonel, G., & Nestle, F. o. Interferon-α and viral triggers promote functional maturation of human monocyte-Derived dendritic cells. Br. J. Dermatol. 158, 921-929 (2008).
59. Palanichamy, A., et al. Neutrophil-mediated IFN activation in the bone marrow alters B cell development in human and murine systemic lupus erythematosus. J. Immunol. Baltim. Md 1950 192, 906-918 (2014).
60. Denny, M. F., et al. A distinct subset of proinflammatory neutrophils isolated from patients with systemic lupus erythematosus induces vascular damage and synthesizes type I IFNs. J. Immunol. Baltim. Md 1950 184, 3284-3297 (2010).
61. Knight, J. S., & Kaplan, M. J. Lupus neutrophils: ?NET? gain in understanding lupus pathogenesis. Curr. Opin. Rheumatol. 24, 441-450 (2012).
62. Hochberg, M. C. Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum. 40, 1725 (1997).
63. Hase, H., et al. BAFF/BLyS can potentiate B-cell selection with the B-cell coreceptor complex. Blood 103, 2257-2265 (2004).